# HS 300431 Containing Insulin global trade data overview...

Reported global trade in containing insulin, for therapeutic or prophylactic uses, packaged for retail sale reached $7.2B in 2024, with five-year annual growth of -5.6%.

## Annual trade evidence

| Year | Global trade | Year-on-year growth | 3-year growth |
| --- | --- | --- | --- |
| 2013 | $10.8B | +17.9% | +9.6% |
| 2014 | $11.9B | +10.2% | +7.7% |
| 2015 | $10.5B | -11.9% | +4.6% |
| 2016 | $9.7B | -7.5% | -3.5% |
| 2017 | $9.1B | -7% | -8.8% |
| 2018 | $9.2B | +1.2% | -4.5% |
| 2019 | $9.6B | +5.1% | -0.3% |
| 2020 | $9.7B | +0.5% | +2.3% |
| 2021 | $9.9B | +2% | +2.5% |
| 2022 | $8.6B | -12.9% | -3.7% |
| 2023 | $8.1B | -6.4% | -5.9% |
| 2024 | $7.2B | -10.4% | -9.9% |

## Leading buyer markets

| Buyer market | Latest imports | 5-year growth | Suppliers |
| --- | --- | --- | --- |
| USA | $952.3M | -14.1% | 23 |
| Germany | $783.2M | +4.1% | 40 |
| Denmark | $369.0M | +0.7% | 24 |
| France | $352.1M | -17.4% | 21 |
| Canada | $335.9M | +1.2% | 27 |
| Mexico | $329.4M | +38% | 17 |
| Saudi Arabia | $188.4M | +0.5% | 12 |
| Romania | $188.3M | +10.3% | 9 |
| Netherlands | $185.3M | +2.3% | 31 |
| Poland | $172.8M | +7% | 15 |
| United Kingdom | $163.0M | -20% | 31 |
| Spain | $162.8M | -12.2% | 14 |

_Source: reported merchandise trade data. Updated 2026-08-14._